Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
Conditions: Anticoagulation; Coronary Endarterectomy Intervention: Drug: Warfarin Sponsor: China National Center for Cardiovascular Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials
Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
Conditions: Anticoagulation; Coronary Endarterectomy Interventions: Drug: Warfarin; Drug: DAPT; Other: CE+CABG Sponsor: China National Center for Cardiovascular Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials
A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
Condition: Liver Cirrhosis Interventions: Drug: Caffeine; Drug: Warfarin sodium; Drug: Omeprazole; Drug: Metoprolol; Drug: Midazolam Sponsor: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials
